Zebrafish Acoustic Startle and Habituation

The zebrafish acoustic startle and habituation assay quantifies the C-start escape response, a rapid (< 15 ms latency) full-body bend triggered by abrupt acoustic or vibrational stimuli, and the progressive reduction of this reflex upon repeated stimulus presentation. The C-start is initiated by the Mauthner cells, a pair of giant reticulospinal neurons in the hindbrain that receive direct input from auditory (otic vesicle) and lateral line afferents, and drive contralateral trunk musculature to produce the characteristic C-shaped body bend. Short-latency C-starts (SLC, < 15 ms) are Mauthner-dependent, while long-latency responses (LLC, 15-80 ms) are mediated by non-Mauthner reticulospinal neurons, providing a dual-component measure of sensorimotor gating.

The protocol delivers a series of identical acoustic or tap stimuli at fixed interstimulus intervals (ISI), typically 1-10 seconds for short-term habituation or 60 seconds for long-term habituation paradigms. Primary dependent variables include startle magnitude (measured as peak angular velocity or displacement of the initial bend), startle probability (percentage of trials eliciting a C-start), response latency, and habituation rate quantified as the exponential decay constant of startle magnitude across successive trials. Prepulse inhibition can be assessed by preceding the startle stimulus with a weaker prepulse at 50-300 ms intervals. Dishabituation is tested by introducing a novel sensory stimulus after habituation is established.

ConductMaze integrates with high-speed camera systems (500-1000 fps) and programmable audio or solenoid tap actuators to deliver precisely timed stimuli and capture the rapid kinematics of C-start responses. The system automatically detects response onset, measures peak bend angle and angular velocity, classifies responses as SLC or LLC based on latency, and fits habituation curves across stimulus blocks. Multi-well plate configurations enable simultaneous recording of 24-96 larvae for high-throughput genetic and pharmacological screens.